L. Zeng

Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients

Youxiang Chen, F. Cheng, Chunyan Zeng, 2019, Medicine.

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.

M. Tsuboi, Jie He, R. Herbst, 2020, The New England journal of medicine.

TLR9 induces colitis-associated colorectal carcinogenesis by regulating NF-κB expression levels

Chao-Tao Tang, Qingtian Luo, Youxiang Chen, 2020, Oncology letters.

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.

M. Tsuboi, R. Herbst, F. Shepherd, 2021, Journal of Thoracic Oncology.

The association of speckle-type POZ protein with lymph node metastasis and prognosis in cancer patients

Youxiang Chen, F. Cheng, Chunyan Zeng, 2019, Medicine.

Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA

M. Tsuboi, Y. Yatabe, S. Dacic, 2021, Future oncology.

OA06.03 Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC

M. Tsuboi, R. Herbst, Yi-long Wu, 2021 .

P03.02 Neoadjuvant Osimertinib with/without Chemotherapy vs Chemotherapy for EGFR Mutated Resectable NSCLC: NeoADAURA

M. Tsuboi, Y. Yatabe, S. Dacic, 2021 .

Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial

M. Tsuboi, R. Herbst, Yi-long Wu, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Analysis of the Incidence and Survival of Gastric Cancer Based on the Lauren Classification: A Large Population-Based Study Using SEER

Youxiang Chen, Chunyan Zeng, L. Zeng, 2020, Frontiers in Oncology.

Prognostic Value of S100P Expression in Patients With Digestive System Cancers: A Meta-Analysis

Xi-jian Dai, Youxiang Chen, F. Cheng, 2021, Frontiers in Oncology.

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.

M. Tsuboi, R. Herbst, F. Shepherd, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.